We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 81-100 of 10,000 results
  1. Effects of different energy levels in low-protein diet on liver lipid metabolism in the late-phase laying hens through the gut-liver axis

    Background

    The energy/protein imbalance in a low-protein diet induces lipid metabolism disorders in late-phase laying hens. Reducing energy levels in...

    Hong Hu, Ying Huang, ... Hongbin Pan in Journal of Animal Science and Biotechnology
    Article Open access 11 July 2024
  2. DCE-MRI to distinguish all monoclonal plasma cell disease stages and correlation with diffusion-weighted MRI/PET-based biomarkers in a hybrid simultaneous whole body-2-[18F]FDG-PET/MRI imaging approach

    Background

    Dynamic contrast-enhanced-MRI (DCE-MRI) is able to study bone marrow angiogenesis in patients with multiple myeloma (MM) and asymptomatic...

    Bastien Jamet, Hatem Necib, ... Francoise Kraeber-Bodere in Cancer Imaging
    Article Open access 11 July 2024
  3. Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma

    Background

    Therapeutic approach used for pancreatic ductal adenocarcinoma is usually translated also for the rarer acinar counterpart, which shows a...

    Valeria Merz, Francesca Maines, ... Orazio Caffo in Journal of Cancer Research and Clinical Oncology
    Article Open access 11 July 2024
  4. Understanding the experience, treatment preferences and goals of people living with chronic lymphocytic leukemia (CLL) in Australia

    Background

    Listening to patient voices is critical, in terms of how people experience their condition as well as their treatment preferences. This...

    Simon Fifer, Jenni Godsell, ... Marija McGeachie in BMC Cancer
    Article Open access 11 July 2024
  5. Exploring the osteogenic potential of semisynthetic triterpenes from Combretum leprosum: An in vitro and in silico study

    Combretum leprosum Mart. is a plant of the Combretaceae family, widely distributed in the Northeast region of Brazil, popularly used as an...

    Valdo Nogueira-Júnior, Fátima Regina N. Sousa, ... Renata F. de C. Leitão in In Vitro Cellular & Developmental Biology - Animal
    Article 11 July 2024
  6. Circ_0000069 promotes the development of hepatocellular carcinoma by regulating CCL25

    Background

    Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths globally, influenced by aberrant circRNA expression....

    Junshao Zeng, Yi Feng, ... Yifan Sun in BMC Cancer
    Article Open access 11 July 2024
  7. Survival after thermal ablation versus wedge resection for stage I non-small cell lung cancer < 1 cm and 1 to 2 cm: evidence from the US SEER database

    Background

    This study compared the survival outcomes after thermal ablation versus wedge resection in patients with stage I non-small cell lung cancer...

    Shelly Yim, Wei Chan Lin, ... Ming Hong Yen in Cancer Imaging
    Article Open access 11 July 2024
  8. Precision public health in the era of genomics and big data

    Precision public health (PPH) considers the interplay between genetics, lifestyle and the environment to improve disease prevention, diagnosis and...

    Megan C. Roberts, Kathryn E. Holt, ... Caitlin G. Allen in Nature Medicine
    Article 11 July 2024
  9. RNA scaffolds the Golgi ribbon by forming condensates with GM130

    The mammalian Golgi is composed of stacks that are laterally connected into a continuous ribbon-like structure. The integrity and function of the...

    Yijun Zhang, Joachim Seemann in Nature Cell Biology
    Article 11 July 2024
  10. Women’s health is on the ballot in 2024

    Sophie Harman in Nature Medicine
    Article 11 July 2024
  11. Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments

    As one of the significant challenges to human health, cancer has long been a focal point in medical treatment. With ongoing advancements in the field...

    Zhuo Yan, Zhengbo Zhang, ... Zhangquan Wang in Cancer Cell International
    Article Open access 11 July 2024
  12. Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion

    Acute myeloid leukemia (AML) is an aggressive and genetically heterogeneous disease with poor clinical outcomes. Refractory AML is common, and...

    Phatchanat Klaihmon, Parinya Samart, ... Sudjit Luanpitpong in Experimental Hematology & Oncology
    Article Open access 11 July 2024
  13. Combination of dual JAK/HDAC inhibitor with regorafenib synergistically reduces tumor growth, metastasis, and regorafenib-induced toxicity in colorectal cancer

    Background

    Treatment with regorafenib, a multiple-kinase inhibitor, to manage metastatic colorectal cancers (mCRCs) shows a modest improvement in...

    Prachi Bajpai, Sumit Agarwal, ... Upender Manne in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  14. Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning “Two Keys” simultaneously

    Background

    Macrophages play important roles in phagocytosing tumor cells. However, tumors escape macrophage phagocytosis in part through the...

    Wen Luo, Hai Hoang, ... Mitchell S. Cairo in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 July 2024
  15. Modulation of gene expression in immune-related organs by in ovo stimulation with probiotics and prophybiotics in broiler chickens

    In ovo stimulation has been studied intensively as an alternative to antibiotic use in poultry production. We investigated the potential use of a...

    Ramesha N. Wishna-Kadawarage, Katarzyna Połtowicz, ... Maria Siwek in Journal of Applied Genetics
    Article Open access 11 July 2024
  16. The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells

    Selinexor, a first-in-class exportin1 (XPO1) inhibitor, is an attractive anti-tumor agent because of its unique mechanisms of action; however, its...

    Tatsuya Terasaki, Yuichiro Semba, ... Takahiro Maeda in Leukemia
    Article 11 July 2024
Did you find what you were looking for? Share feedback.